Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis

Platelets

Volumn 25, Issue 4, 2014, Pages 257-263

  Rahman, Milladur ^a   Gustafsson, David ^b   Wang, Yongzhi ^a   Thorlacius, Henrik ^a   Braun, Oscar Ö ^a  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Inflammation; Leukocytes; P2Y12; Platelets; Sepsis

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND; CXCL3 CHEMOKINE; TICAGRELOR; ADENOSINE; ALPHA CHEMOKINE; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECAL LIGATION AND PUNCTURE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FLOW CYTOMETRY; GASTROINTESTINAL SURGERY; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; LUNG EDEMA; LUNG INJURY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY NEUTROPHIL RECRUITMENT; SEPSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PULMONARY EDEMA; THROMBOCYTE;

ADENOSINE; ANIMALS; BLOOD PLATELETS; CHEMOKINES, CXC; DISEASE MODELS, ANIMAL; LUNG INJURY; MACROPHAGE-1 ANTIGEN; MALE; MICE; NEUTROPHIL INFILTRATION; NEUTROPHILS; PLATELET AGGREGATION; PULMONARY EDEMA; PURINERGIC P2Y RECEPTOR ANTAGONISTS; SEPSIS;

EID: 84899943554     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.809520     Document Type: Article

References (39)

1. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007;35: 1244-1250
2. Gustot T. Multiple organ failure in sepsis: Prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011;17: 153-159
3. Simon GL, Gorbach SL. Intestinal flora in health and disease. Gastroenterology 1984;86:174-193
4. Gorbach SL, Bartlett JG. Anaerobic infections. 1. N Engl J Med 1974;290:1177-1184
5. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-1477
6. Asaduzzaman M, Zhang S, Lavasani S, Wang Y, Thorlacius H. LFA-1 and MAC-1 mediate pulmonary recruitment of neutrophils and tissue damage in abdominal sepsis. Shock 2008;30: 254-259
7. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8: 1227-1234
8. Braun OO, Johnell M, Varenhorst C, James S, Brandt JT, Jakubowski JA, Winters KJ, Wallentin L, Erlinge D, Siegbahn A. Greater reduction of platelet activation markers and plateletmonocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease. Thromb Haemost 2008;100:626-633
9. Li N, Hu H, Lindqvist M, Wikström-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000;20:2702-2708
10. Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, Thorlacius H. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med 2009;37: 1389-1396
11. Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg 2009;250: 783-790
12. Eckly A, Gendrault JL, Hechler B, Cazenave JP, Gachet C. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 2001;85:694-701
13. Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, Spannagl M, Gachet C, Engelmann B. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004; 103:594-600
14. Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000;110:925-934
15. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, Junger WG. Purinergic signaling: A fundamental mechanism in neutrophil activation. Sci Signal 2010; 3-45
16. Ben Yebdri F, Kukulski F, Tremblay A, Sévigny J. Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol 2009;39:2885-2894
17. Projahn D, Koenen RR. Platelets: Key players in vascular inflammation. J Leukocyte Biol 2012;92:1167-1175
18. Judge HM, Buckland RJ, Holgate CE, Storey RF. Glycoprotein IIb/ IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses. Platelets 2005;16:398-407
19. Varenhorst C, Alström U, Scirica BM, Hogue CW, Åsenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, et al. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 2012;60:1623-1630
20. van Giezen JJJ, Sidaway J, Glaves P, Kirk I, Björkman J-A. Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. J Cardiovasc Pharmacol Ther 2012;17:164-172
21. Hasan Z, Rahman M, Palani K, Syk I, Jeppsson B, Thorlacius H. Geranylgeranyl transferase regulates CXC chemokine formation in alveolar macrophages and neutrophil recruitment in septic lung injury. Am J Physiol Lung Cell Mol Physiol 2012;304:L221-229
22. Patil SB, Jackman LE, Francis SE, Judge HM, Nylander S, Storey RF. Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima. Arterioscler Thromb Vasc Biol 2010;30:2385-2391
23. He P, Zhang H, Zhu L, Jiang Y, Zhou X. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: Role of activated endothelial cells. Am J Physiol Heart Circ Physiol 2006;291:H591-H599
24. Yoshida K, Kondo R, Wang Q, Doerschuk CM. Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats. Am J Respir Crit Care Med 2006;174: 689-698
25. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537
26. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review. Chest 2011;139:271-278
27. Lösche W, Boettel J, Kabisch B, Winning J, Claus RA, Bauer M. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients?. Thrombosis 2012;2012:720254
28. Otto GP, Sossdorf M, Boettel J, Kabisch B, Breuel H, Winning J, Lösche W. Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets 2012 [Epub ahead of print]. DOI: 10.3109/ 09537104.2012.724482
29. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, Claus RA, Bauer M, Lösche W. Anti-platelet drugs and outcome in severe infection: Clinical impact and underlying mechanisms. Platelets 2009;20:50-57
30. Reutershan J, Basit A, Galkina EV, Ley K. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPSinduced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;289:L807-L815
31. Wang Y, Roller J, Menger MD, Thorlacius H. Sepsis-induced leukocyte adhesion in the pulmonary microvasculature in vivo is mediated by CD11a and CD11b. Eur J Pharmacol 2013;702: 135-141
32. Motosugi H, Graham L, Noblitt TW, Doyle NA, Quinlan WM, Li Y, Doerschuk CM. Changes in neutrophil actin and shape during sequestration induced by complement fragments in rabbits. Am J Pathol 1996;149:963-973
33. Worthen GS, Schwab B, Elson EL, Downey GP. Mechanics of stimulated neutrophils: Cell stiffening induces retention in capillaries. Science 1989;245:183-186
34. Laschke MW, Dold S, Menger MD, Jeppsson B, Thorlacius H. Platelet-dependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis. Br J Pharmacol 2008;153:148-156
35. Downey GP, Worthen GS. Neutrophil retention in model capillaries: Deformability, geometry, and hydrodynamic forces. J Appl Physiol 1988;65:1861-1871
36. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 2009;169:788-796
37. Hagiwara S, Iwasaka H, Hasegawa A, Oyama M, Imatomi R, Uchida T, Noguchi T. Adenosine diphosphate receptor antagonist clopidogrel sulfate attenuates LPS-induced systemic inflammation in a rat model. Shock 2011;35:289-292
38. Garcia AE, Mada SR, Rico MC, Cadena Dela RA, Kunapuli SP. Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharideinduced arthritis. PLoS One 2011;6:e26035
39. Teng R, Butler K. Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects. Eur J Clin Pharmacol 2010;66:487-496